Modulation of LMP1 protein expression by EBV-encoded microRNAs
暂无分享,去创建一个
Kwok Wai Lo | K. To | R. W. Lung | G. Liao | S. Hayward | K. Lo | Angela Kwok Fung Lo | Gangling Liao | Ka Fai To | Raymond Wai Ming Lung | Jan Wai Ying Hui | S Diane Hayward | A. K. Lo | Jan Wai-Ying Hui | Gangling Liao
[1] E. Hui,et al. Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays. , 2006, The Journal of general virology.
[2] D. Walling,et al. Oncogenic Activity of Epstein-Barr Virus Latent Membrane Protein 1 (LMP-1) Is Down-Regulated by Lytic LMP-1 , 2006, Journal of Virology.
[3] G. Bornkamm,et al. Autoactivation of the Epstein-Barr Virus Oncogenic Protein LMP1 during Type II Latency through Opposite Roles of the NF-κB and JNK Signaling Pathways , 2006, Journal of Virology.
[4] B. Cullen. Viruses and microRNAs , 2006, Nature Genetics.
[5] Adam Grundhoff,et al. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. , 2006, RNA.
[6] Alexandra Schäfer,et al. Epstein–Barr Virus MicroRNAs Are Evolutionarily Conserved and Differentially Expressed , 2006, PLoS pathogens.
[7] Stijn van Dongen,et al. miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..
[8] D. Stevenson,et al. Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9. , 2005, Cancer research.
[9] L. Young,et al. Epstein–Barr virus: 40 years on , 2004, Nature Reviews Cancer.
[10] Anton J. Enright,et al. Identification of Virus-Encoded MicroRNAs , 2004, Science.
[11] Yu-Ting Chang,et al. Epstein–Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells , 2004, Oncogene.
[12] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[13] N. Raab-Traub,et al. Potential Selection of LMP1 Variants in Nasopharyngeal Carcinoma , 2004, Journal of Virology.
[14] E. Kieff,et al. Epstein–Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKKα-dependent noncanonical NF-κB activation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[15] L. Young,et al. Epstein–Barr virus and oncogenesis: from latent genes to tumours , 2003, Oncogene.
[16] Y. Wong,et al. Alterations of Biologic Properties and Gene Expression in Nasopharyngeal Epithelial Cells by the Epstein-Barr Virus–Encoded Latent Membrane Protein 1 , 2003, Laboratory Investigation.
[17] L. Hutt-Fletcher,et al. A Positive Autoregulatory Loop of LMP1 Expression and STAT Activation in Epithelial Cells Latently Infected with Epstein-Barr Virus , 2003, Journal of Virology.
[18] J. Minárovits,et al. Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation. , 2003, Advances in cancer research.
[19] N. Raab-Traub. Epstein-Barr virus in the pathogenesis of NPC. , 2002, Seminars in cancer biology.
[20] S. Tsao,et al. The significance of LMP1 expression in nasopharyngeal carcinoma. , 2002, Seminars in cancer biology.
[21] S. Tsao,et al. Latent membrane protein‐1 of Epstein‐Barr virus inhibits cell growth and induces sensitivity to cisplatin in nasopharyngeal carcinoma cells , 2002, Journal of medical virology.
[22] P. Smith. Epstein-Barr virus complementary strand transcripts (CSTs/BARTs) and cancer. , 2001, Seminars in cancer biology.
[23] M. Kawanishi. The Epstein-Barr virus latent membrane protein 1 (LMP1) enhances TNF alpha-induced apoptosis of intestine 407 epithelial cells: the role of LMP1 C-terminal activation regions 1 and 2. , 2000, Virology.
[24] Philip Smith,et al. Structure and Coding Content of CST (BART) Family RNAs of Epstein-Barr Virus , 2000, Journal of Virology.
[25] B. Rayet,et al. Aberrant rel/nfkb genes and activity in human cancer , 1999, Oncogene.
[26] E. Kieff,et al. The Epstein–Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB , 1997 .
[27] E. Kieff,et al. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator. , 1996, Oncogene.
[28] J. Chen,et al. Induction of apoptosis in epithelial cells by Epstein-Barr virus latent membrane protein 1. , 1996, The Journal of general virology.
[29] L. Young,et al. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells , 1993, The Journal of experimental medicine.
[30] J. Sham,et al. Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells. , 1992, Virology.
[31] Philip Smith,et al. Expression of a family of complementary-strand transcripts in Epstein-Barr virus-infected cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[32] M. Abdel-hamid,et al. Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo , 1991, Journal of virology.
[33] I. Ernberg,et al. Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region , 1991, Journal of virology.